IP Library Granted Patent US 7,078,023
Granted Patent B1
US 7,078,023 · App. 09/675,938 · Granted Jul 18, 2006

Foot and shoe deodorant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,078,023
App. No.
09/675,938
Granted
Jul 18, 2006
Kind
B1
Abstract

A pressurized aerosol and concentrate are described for treating moderate to severe foot and/or shoe odors. The aerosol contains micronized zinc oxide, a propellant and a solvent. Optionally, the aerosol may also contain a fragrance, a thickening agent and/or a base.

Claims (14)

1. A pressurized aerosol composition for treating foot and shoe disorders, consisting essentially of

a) micronized zinc oxide;

b) a propellant for expelling contents of an aerosol container when pressure is released, wherein said propellant is present in an amount of about 40% to about 85%;

c) about 4 to about 50 percent of a solvent selected from the group consisting of water and C 1 to C 3 alcohols, wherein said pressurized aerosol composition is for treating foot and shoe disorders.

2. The composition according to claim 1 further comprising a fragrance to help mask any foot odors and/or provide a more pleasant odor to the foot or shoe.

3. The composition according to claim 1 further comprising a thickening agent capable of thickening the contents of the aerosol.

4. The composition according to claim 1 further comprising a base to neutralize any organic or inorganic acids.

5. The composition according to claim 1 , wherein the amount of micronized zinc oxide in the aerosol is in the range of from about 0.5% to about 15% by weight.

6. The composition according to claim 5 , wherein the amount of micronized zinc oxide in the aerosol is in the range of from about 2% to about 12% by weight.

7. The composition according to claim 6 , wherein the amount of micronized zinc oxide in the aerosol is in the range of from about 3% to about 10% by weight.

8. The composition according to claim 1 , wherein the average particle size of the zinc oxide is in the range from about 26 to about 46 nanometers.

9. The composition according to claim 2 , wherein the average particle size of the zinc oxide is in the range from about 30 to about 40 nanometers.

10. The composition according to claim 9 , wherein the average particle size of the zinc oxide is in the range from about 35 to about 37 nanometers.

11. A method of inhibiting foot or shoe odor comprising administering to a foot or shoe the Composition of claim 1 .

Assignments (7)
SECURITY INTEREST Recorded Nov 4, 2019
From: DRS ACQUISITION LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 050917/0722 →
CHANGE OF NAME Recorded Nov 4, 2019
From: DRS ACQUISITION LLC
To: SCHOLL'S WELLNESS COMPANY LLC
Reel/Frame 050925/0925 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2019
From: BAYER HEALTHCARE LLC
To: DRS ACQUISITION LLC
Reel/Frame 050913/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2019
From: DR. SCHOLL'S LLC
To: BAYER HEALTHCARE LLC
Reel/Frame 048741/0376 →
CHANGE OF NAME Recorded Mar 20, 2019
From: BAYER CONSUMER CARE HOLDINGS LLC
To: DR. SCHOLL'S LLC
Reel/Frame 048650/0498 →
CHANGE OF NAME Recorded Mar 19, 2019
From: MSD CONSUMER CARE HOLDINGS LLC
To: BAYER CONSUMER CARE HOLDINGS LLC
Reel/Frame 048638/0753 →
CHANGE OF NAME Recorded Jul 14, 2011
From: SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC.
To: MSD CONSUMER CARE, INC.
Reel/Frame 026594/0364 →